| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Advances in Brief |
Molecular Angiogenesis Laboratory [N. S. B., R. B.] and Molecular Oncology Group [A. J., C. F., A. L. H.], Imperial Cancer Research Fund, Weatherall Institute of Molecular Medicine, University of Oxford, John Radcliffe Hospital, Oxford OX3 9DS, and Department of Urology, Churchill Hospital, Oxford OX3 7LJ [A. J.], United Kingdom
Thymidine phosphorylase (TP) (E.C. 2.4.2.4), also known as platelet-derived endothelial cell growth factor, is a potent angiogenic factor. The expression of TP correlates with poor prognosis in a range of tumor types. 2-Deoxy-D-ribose-1-phosphate, a product of thymidine catabolism by TP, is a strongly reducing sugar that generates oxygen radical species during the early stages of protein glycation. We show that thymidine induces oxidative stress in TP-overexpressing carcinoma cells, promoting secretion of the stress-induced angiogenic factors vascular endothelial growth factor and interleukin-8, and inducing matrix metalloproteinase-1. Our findings outline a putative mechanism for TP-induced angiogenesis and identify novel targets for intervention.
This article has been cited by other articles:
![]() |
E. J. Yu, Y. Lee, S. Y. Rha, T. S. Kim, H. C. Chung, B. K. Oh, W. I. Yang, S. H. Noh, and H.-C. Jeung Angiogenic Factor Thymidine Phosphorylase Increases Cancer Cell Invasion Activity in Patients with Gastric Adenocarcinoma Mol. Cancer Res., October 1, 2008; 6(10): 1554 - 1566. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Callaghan, E. Crowley, S. Potter, and I. D. Kerr P-glycoprotein: So Many Ways to Turn It On J. Clin. Pharmacol., March 1, 2008; 48(3): 365 - 378. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. P. Mitra, R. H. Datar, and R. J. Cote Molecular Pathways in Invasive Bladder Cancer: New Insights Into Mechanisms, Progression, and Target Identification J. Clin. Oncol., December 10, 2006; 24(35): 5552 - 5564. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Liekens, A. Bronckaers, A.-I. Hernandez, E.-M. Priego, E. Casanova, M.-J. Camarasa, M.-J. Perez-Perez, and J. Balzarini 5'-O-Tritylated Nucleoside Derivatives: Inhibition of Thymidine Phosphorylase and Angiogenesis Mol. Pharmacol., August 1, 2006; 70(2): 501 - 509. [Abstract] [Full Text] [PDF] |
||||
![]() |
E Sivridis, A Giatromanolaki, and M I Koukourakis Proliferating fibroblasts at the invading tumour edge of colorectal adenocarcinomas are associated with endogenous markers of hypoxia, acidity, and oxidative stress J. Clin. Pathol., October 1, 2005; 58(10): 1033 - 1038. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Li, K. Tanaka, K. Morioka, T. Uesaka, N. Yamada, A. Takamori, M. Handa, S. Tanabe, and A. Ihaya Thymidine Phosphorylase Gene Transfer Inhibits Vascular Smooth Muscle Cell Proliferation by Upregulating Heme Oxygenase-1 and p27KIP1 Arterioscler Thromb Vasc Biol, July 1, 2005; 25(7): 1370 - 1375. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Liekens, A.-I. Hernandez, D. Ribatti, E. De Clercq, M.-J. Camarasa, M.-J. Perez-Perez, and J. Balzarini The Nucleoside Derivative 5'-O-Trityl-inosine (KIN59) Suppresses Thymidine Phosphorylase-triggered Angiogenesis via a Noncompetitive Mechanism of Action J. Biol. Chem., July 9, 2004; 279(28): 29598 - 29605. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Nakajima, T. Gotanda, H. Uchimiya, T. Furukawa, M. Haraguchi, R. Ikeda, T. Sumizawa, H. Yoshida, and S.-i. Akiyama Inhibition of Metastasis of Tumor Cells Overexpressing Thymidine Phosphorylase by 2-Deoxy-L-Ribose Cancer Res., March 1, 2004; 64(5): 1794 - 1801. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Seeliger, M. Guba, G. E. Koehl, A. Doenecke, M. Steinbauer, C. J. Bruns, C. Wagner, E. Frank, K.-W. Jauch, and E. K. Geissler Blockage of 2-Deoxy-D-Ribose-Induced Angiogenesis with Rapamycin Counteracts a Thymidine Phosphorylase-Based Escape Mechanism Available for Colon Cancer under 5-Fluorouracil Therapy Clin. Cancer Res., March 1, 2004; 10(5): 1843 - 1852. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. I. T. Sihvo, T. Ruohtula, M. I. Auvinen, A. Koivistoinen, A. L. Harjula, and J. A. Salo Simultaneous progression of oxidative stress and angiogenesis in malignant transformation of Barrett esophagus J. Thorac. Cardiovasc. Surg., January 1, 2004; 126(6): 1952 - 1957. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. I. Koukourakis, A. Giatromanolaki, R. A. Brekken, E. Sivridis, K. C. Gatter, A. L. Harris, and E. H. Sage Enhanced Expression of SPARC/Osteonectin in the Tumor-associated Stroma of Non-Small Cell Lung Cancer Is Correlated with Markers of Hypoxia/ Acidity and with Poor Prognosis of Patients Cancer Res., September 1, 2003; 63(17): 5376 - 5380. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. A. Hotchkiss, A. W. Ashton, R. S. Klein, M. L. Lenzi, G. H. Zhu, and E. L. Schwartz Mechanisms by Which Tumor Cells and Monocytes Expressing the Angiogenic Factor Thymidine Phosphorylase Mediate Human Endothelial Cell Migration Cancer Res., January 15, 2003; 63(2): 527 - 533. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Giatromanolaki, E. Sivridis, C. Simopoulos, A. Polychronidis, K. C. Gatter, A. L. Harris, and M. I. Koukourakis Thymidine Phosphorylase Expression in Gallbladder Adenocarcinomas International Journal of Surgical Pathology, July 1, 2002; 10(3): 181 - 188. [Abstract] [PDF] |
||||
![]() |
C.S. Brock and S.M. Lee Anti-angiogenic strategies and vascular targeting in the treatment of lung cancer Eur. Respir. J., March 1, 2002; 19(3): 557 - 570. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. D. Leek, K. L. Talks, F. Pezzella, H. Turley, L. Campo, N. S. Brown, R. Bicknell, M. Taylor, K. C. Gatter, and A. L. Harris Relation of Hypoxia-inducible Factor-2{alpha} (HIF-2{alpha}) Expression in Tumor-infiltrative Macrophages to Tumor Angiogenesis and the Oxidative Thymidine Phosphorylase Pathway in Human Breast Cancer Cancer Res., March 1, 2002; 62(5): 1326 - 1329. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Yao, T. Kubota, K. Sato, and R. Kitai Macrophage Infiltration-associated Thymidine Phosphorylase Expression Correlates with Increased Microvessel Density and Poor Prognosis in Astrocytic Tumors Clin. Cancer Res., December 1, 2001; 7(12): 4021 - 4026. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |